Orbimed Advisors as of Dec. 31, 2021
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 158 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 4.8 | $374M | 6.0M | 61.98 | |
| Bristol Myers Squibb (BMY) | 3.5 | $271M | 4.3M | 62.35 | |
| Horizon Therapeutics Pub L SHS | 3.5 | $269M | 2.5M | 107.76 | |
| Boston Scientific Corporation (BSX) | 3.0 | $236M | 5.6M | 42.48 | |
| Theseus Pharmaceuticals | 2.7 | $214M | 17M | 12.68 | |
| Edgewise Therapeutics (EWTX) | 2.7 | $213M | 14M | 15.28 | |
| Mirati Therapeutics | 2.7 | $209M | 1.4M | 146.69 | |
| Pmv Pharmaceuticals (PMVP) | 2.2 | $169M | 7.3M | 23.10 | |
| Pfizer (PFE) | 2.0 | $154M | 2.6M | 59.05 | |
| Ikena Oncology Nonvoting | 1.9 | $149M | 12M | 12.54 | |
| Humana (HUM) | 1.9 | $148M | 318k | 463.86 | |
| Abbvie (ABBV) | 1.9 | $145M | 1.1M | 135.40 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $145M | 658k | 219.60 | |
| Edwards Lifesciences (EW) | 1.8 | $139M | 1.1M | 129.55 | |
| Merck & Co (MRK) | 1.8 | $136M | 1.8M | 76.64 | |
| UnitedHealth (UNH) | 1.7 | $136M | 271k | 502.14 | |
| Intuitive Surgical Com New (ISRG) | 1.7 | $134M | 374k | 359.30 | |
| Natera (NTRA) | 1.7 | $132M | 1.4M | 93.39 | |
| Adicet Bio (ACET) | 1.7 | $130M | 7.4M | 17.49 | |
| Arcutis Biotherapeutics (ARQT) | 1.6 | $126M | 6.1M | 20.74 | |
| Prelude Therapeutics (PRLD) | 1.6 | $125M | 10M | 12.45 | |
| Stryker Corporation (SYK) | 1.6 | $124M | 465k | 267.42 | |
| Guardant Health (GH) | 1.6 | $123M | 1.2M | 100.02 | |
| Iovance Biotherapeutics (IOVA) | 1.6 | $121M | 6.3M | 19.09 | |
| Spdr Ser Tr S&p Biotech (XBI) | 1.5 | $113M | 1.0M | 111.96 | |
| Seagen | 1.3 | $101M | 656k | 154.60 | |
| Turning Point Therapeutics I | 1.3 | $101M | 2.1M | 47.70 | |
| Hca Holdings (HCA) | 1.3 | $100M | 390k | 256.92 | |
| Tricida | 1.3 | $98M | 10M | 9.56 | |
| Keros Therapeutics (KROS) | 1.3 | $98M | 1.7M | 58.51 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.2 | $91M | 3.2M | 28.41 | |
| Meiragtx Holdings (MGTX) | 1.1 | $89M | 3.7M | 23.74 | |
| Dex (DXCM) | 1.1 | $82M | 153k | 536.95 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $79M | 932k | 85.17 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $76M | 861k | 88.35 | |
| Sinovac Biotech SHS | 0.9 | $73M | 2.8M | 25.60 | |
| Zimmer Holdings (ZBH) | 0.9 | $72M | 564k | 127.04 | |
| Repare Therapeutics Ord (RPTX) | 0.9 | $70M | 3.3M | 21.09 | |
| Compass Therapeutics (CMPX) | 0.9 | $69M | 22M | 3.17 | |
| Kinnate Biopharma | 0.9 | $68M | 3.8M | 17.72 | |
| Theravance Biopharma (TBPH) | 0.8 | $66M | 6.0M | 11.05 | |
| Thermo Fisher Scientific (TMO) | 0.8 | $63M | 95k | 667.24 | |
| Abcellera Biologics (ABCL) | 0.8 | $60M | 4.2M | 14.30 | |
| Silverback Therapeutics (SPRY) | 0.7 | $58M | 8.7M | 6.66 | |
| Alpine Immune Sciences | 0.7 | $57M | 4.1M | 13.85 | |
| Janux Therapeutics (JANX) | 0.7 | $56M | 2.8M | 19.73 | |
| Biogen Idec (BIIB) | 0.7 | $55M | 230k | 239.92 | |
| Si-bone (SIBN) | 0.7 | $51M | 2.3M | 22.21 | |
| 89bio (ETNB) | 0.6 | $49M | 3.7M | 13.07 | |
| Gracell Biotechnologies Sponsored Ads | 0.6 | $48M | 7.9M | 6.04 | |
| Passage Bio | 0.6 | $44M | 7.0M | 6.35 | |
| Syndax Pharmaceuticals (SNDX) | 0.6 | $43M | 2.0M | 21.89 | |
| Oak Street Health | 0.5 | $43M | 1.3M | 33.14 | |
| Xtant Med Hldgs Com New (XTNT) | 0.5 | $41M | 73M | 0.56 | |
| Neuropace (NPCE) | 0.5 | $40M | 4.0M | 10.08 | |
| Galapagos Nv Spon Adr (GLPG) | 0.5 | $40M | 717k | 55.13 | |
| Tela Bio (TELA) | 0.5 | $39M | 3.0M | 12.80 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $38M | 5.7M | 6.72 | |
| Ikena Oncology (IKNA) | 0.5 | $37M | 2.9M | 12.54 | |
| Select Medical Holdings Corporation (SEM) | 0.5 | $36M | 1.2M | 29.40 | |
| Adagio Therapeutics (IVVD) | 0.5 | $36M | 5.0M | 7.26 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $34M | 2.3M | 14.70 | |
| Nanostring Technologies (NSTGQ) | 0.4 | $34M | 807k | 42.23 | |
| Gh Research Ordinary Shares (GHRS) | 0.4 | $33M | 1.4M | 23.33 | |
| Sierra Oncology Com New | 0.4 | $32M | 1.5M | 21.74 | |
| Cytek Biosciences (CTKB) | 0.4 | $31M | 1.9M | 16.32 | |
| ImmunoGen | 0.4 | $29M | 3.9M | 7.42 | |
| Mereo Biopharma Group Ads (Principal) (MREO) | 0.4 | $28M | 17M | 1.60 | |
| Terns Pharmaceuticals (TERN) | 0.3 | $27M | 3.8M | 7.07 | |
| Vaxcyte (PCVX) | 0.3 | $26M | 1.1M | 23.79 | |
| Erasca (ERAS) | 0.3 | $26M | 1.7M | 15.58 | |
| Evolent Health Cl A (EVH) | 0.3 | $26M | 938k | 27.67 | |
| Vectivbio Hldg Ord Shs | 0.3 | $26M | 5.2M | 4.91 | |
| Ventyx Biosciences (VTYX) | 0.3 | $26M | 1.3M | 19.86 | |
| Vistagen Therapeutics Com New | 0.3 | $25M | 13M | 1.95 | |
| Tenet Healthcare Corp Com New (THC) | 0.3 | $24M | 299k | 81.69 | |
| Singular Genomics Systems In | 0.3 | $24M | 2.1M | 11.56 | |
| Scpharmaceuticals (SCPH) | 0.3 | $24M | 4.8M | 5.02 | |
| Jounce Therapeutics | 0.3 | $24M | 2.9M | 8.35 | |
| Chinook Therapeutics | 0.3 | $23M | 1.4M | 16.31 | |
| Decibel Therapeutics | 0.3 | $23M | 4.9M | 4.65 | |
| Harpoon Therapeutics | 0.3 | $22M | 2.9M | 7.55 | |
| Gilead Sciences (GILD) | 0.3 | $21M | 288k | 72.61 | |
| Applied Therapeutics (APLT) | 0.3 | $21M | 2.3M | 8.95 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $20M | 631k | 31.24 | |
| Logicbio Therapeutics | 0.3 | $20M | 8.5M | 2.31 | |
| Graphite Bio | 0.3 | $20M | 1.6M | 12.43 | |
| Mersana Therapeutics | 0.2 | $18M | 2.9M | 6.22 | |
| Chemomab Therapeutics Sponsored Ads | 0.2 | $18M | 2.6M | 6.90 | |
| Danaher Corporation 5% Conv Pfd B (Principal) | 0.2 | $17M | 10k | 1738.20 | |
| Curis Com New | 0.2 | $17M | 3.6M | 4.76 | |
| Illumina (ILMN) | 0.2 | $17M | 45k | 380.44 | |
| Gemini Therapeutics | 0.2 | $17M | 5.8M | 2.91 | |
| Milestone Pharmaceuticals (MIST) | 0.2 | $17M | 2.6M | 6.55 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $17M | 6.9M | 2.41 | |
| Nextcure (NXTC) | 0.2 | $16M | 2.7M | 6.00 | |
| Celldex Therapeutics Com New (CLDX) | 0.2 | $16M | 406k | 38.64 | |
| Rxsight (RXST) | 0.2 | $16M | 1.4M | 11.25 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $15M | 3.8M | 3.92 | |
| Synlogic | 0.2 | $15M | 6.0M | 2.42 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $14M | 986k | 14.54 | |
| Aeglea Biotherapeutics | 0.2 | $14M | 3.0M | 4.75 | |
| Pulmonx Corp (LUNG) | 0.2 | $14M | 435k | 32.07 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $14M | 3.2M | 4.33 | |
| Burning Rock Biotech Sponsored Ads | 0.2 | $14M | 1.5M | 9.53 | |
| Fusion Pharmaceuticals | 0.2 | $13M | 3.2M | 4.17 | |
| Amgen (AMGN) | 0.2 | $13M | 57k | 224.97 | |
| Cybin Ord | 0.2 | $13M | 11M | 1.19 | |
| Cullinan Oncology (CGEM) | 0.2 | $12M | 805k | 15.43 | |
| Galecto | 0.2 | $12M | 4.1M | 3.03 | |
| Uniqure Nv SHS (QURE) | 0.2 | $12M | 586k | 20.74 | |
| Bellus Health Com New | 0.2 | $12M | 1.5M | 8.04 | |
| Sonendo (SONX) | 0.1 | $11M | 2.0M | 5.76 | |
| 9 Meters Biopharma | 0.1 | $10M | 10M | 0.98 | |
| Magenta Therapeutics | 0.1 | $10M | 2.3M | 4.43 | |
| Prometheus Biosciences | 0.1 | $9.9M | 250k | 39.54 | |
| Imara | 0.1 | $9.9M | 4.4M | 2.25 | |
| Vor Biopharma (VOR) | 0.1 | $9.7M | 833k | 11.62 | |
| Acutus Medical (AFIB) | 0.1 | $9.0M | 2.6M | 3.41 | |
| CVRX (CVRX) | 0.1 | $8.8M | 723k | 12.23 | |
| Rapt Therapeutics | 0.1 | $8.0M | 217k | 36.73 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $7.9M | 1.6M | 5.01 | |
| Gossamer Bio (GOSS) | 0.1 | $7.7M | 683k | 11.31 | |
| Graybug Vision Com Shs | 0.1 | $7.6M | 4.2M | 1.83 | |
| Oncocyte | 0.1 | $7.6M | 3.5M | 2.17 | |
| Nautilus Biotechnology (NAUT) | 0.1 | $7.5M | 1.5M | 5.18 | |
| Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $7.2M | 6.0M | 1.20 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $6.3M | 536k | 11.79 | |
| Intellia Therapeutics (NTLA) | 0.1 | $6.3M | 53k | 118.23 | |
| Syros Pharmaceuticals | 0.1 | $6.0M | 1.8M | 3.26 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $5.6M | 831k | 6.75 | |
| Nurix Therapeutics (NRIX) | 0.1 | $5.3M | 185k | 28.95 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $5.3M | 59k | 90.05 | |
| I Mab Sponsored Ads (IMAB) | 0.1 | $5.3M | 111k | 47.39 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $5.0M | 500k | 10.08 | |
| Century Therapeutics (IPSC) | 0.1 | $4.9M | 307k | 15.86 | |
| Chardan Healthcare Acqu- Ord | 0.1 | $4.5M | 2.8M | 1.60 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $4.5M | 208k | 21.49 | |
| Inflarx Nv (IFRX) | 0.1 | $4.2M | 875k | 4.76 | |
| Talaris Therapeutics | 0.0 | $3.8M | 247k | 15.29 | |
| Field Trip Health Ord | 0.0 | $3.7M | 1.5M | 2.42 | |
| Inozyme Pharma (INZY) | 0.0 | $3.6M | 527k | 6.82 | |
| Sight Sciences (SGHT) | 0.0 | $3.5M | 200k | 17.57 | |
| X4 Pharmaceuticals | 0.0 | $3.1M | 1.4M | 2.29 | |
| Aadi Bioscience (WHWK) | 0.0 | $3.1M | 128k | 24.15 | |
| Exscientia Ads (EXAI) | 0.0 | $2.5M | 125k | 19.76 | |
| Surface Oncology | 0.0 | $2.2M | 468k | 4.78 | |
| Aslan Pharmaceuticals Ads | 0.0 | $2.2M | 2.0M | 1.12 | |
| Bright Minds Biosciences | 0.0 | $2.1M | 661k | 3.23 | |
| Adagene Ads (ADAG) | 0.0 | $2.1M | 263k | 8.07 | |
| Aptinyx | 0.0 | $2.0M | 750k | 2.67 | |
| Catalyst Biosciences Com New | 0.0 | $1.6M | 1.7M | 0.91 | |
| Pyxis Oncology Common Stock (PYXS) | 0.0 | $1.6M | 144k | 10.97 | |
| Landos Biopharma | 0.0 | $1.4M | 283k | 4.80 | |
| Cabaletta Bio (CABA) | 0.0 | $1.1M | 303k | 3.79 | |
| Longboard Pharmaceuticals In | 0.0 | $554k | 114k | 4.88 | |
| Augmedix (AUGX) | 0.0 | $278k | 88k | 3.15 | |
| Owlet *w Exp 09/14/202 (OWLTW) | 0.0 | $86k | 221k | 0.39 |
